van Vugt LK, Tegzess E, van der Zwan M, Clahsen-van Groningen MC, et al. Multicenter, Real-World Clinical Evaluation of Alemtuzumab and Anti-Thymocyte Globulin for Severe Acute T Cell-Mediated Kidney Transplant Rejection. Clin Transplant 2024;38:e70046.
PMID: 39636744